DCT

2:09-cv-06383

Merck Sharp & Dohme Corp v. Mylan Pharma Inc

General

Filed

12/16/09

Cause of ActionInfringement

SectorBiotech

Status

Closed (12/04/12)

Patent Owner

Operating Company (W)

SourcePACER

Appeals12-1434

CourtD. New Jersey

Judge	Period	PO Win Rate
Jose L. Linares	03/05/10 - 02/07/13	80%

MagistrateClaire C. Cecchi, Esther Salas, Mark Falk, Michael A. Hammer

Plaintiff

Party

Name	Ratings
Merck Sharp & Dohme Corp	L5A
Schering Corp	L5A
MSD Intl GmbH	L5A
Merck Sharp & Dohme LLC	L5A
MSP Singapore Co LLC	L1B

Attorney

Name	Ratings
Sidley Austin LLP	L5A
Todd L. Krause	L5A
David T. Pritikin	L4A
William H. Baumgartner, Jr.	L4A
Peter S. Choi	L4B
James Suh	L2C
Lowenstein SandlerLocal	L2A
Douglas S. Eakeley	L4A
Jason E. Halper	L3A
Cristina Baragona	---- --
Cristina Finetti	---- --
Robinson MillerLocal	L1A
Donald A. Robinson	L2A
Attorney at LawLocal	---- --
David M. Goldstein	---- --
Ross C. Paolino	---- --

Defendant

Party

Name	Ratings
Mylan Inc	L5C
Mylan Pharmaceuticals Inc	L3B
Teva Pharmaceuticals USA Inc	L5E
Teva Pharmaceutical Industries Ltd	L5E
Mylan NV	L3B

Attorney

Name	Ratings
Alston & Bird LLP	L5A
Blas P. Arroyo	L4C
John W. Cox	L4C
Thomas J. Parker	L4D
Deepro Mukerjee	L4D
Natalie C. Clayton	L3D
Srilakshmi M. Ravi	L3D
Jitendra Malik	L2B
Matthew J. McNeill	---- --
Rodney J. Ganske	---- --
Michael P. Kenny	---- --
Adam J. Biegel	---- --
SaiberLocal	L3E
Arnold B. Calmann	L5E
Jeffrey S. Soos	L5E
Jakob B. Halpern	L3B
Rita D. Turner	L1C
Patunas TarantinoLocal	L2E
Michael E. Patunas	L5E